Member Info for sphinx100

Thanks Gixer ,that’s about £53b revenue . Massive company on a global platform , is this one of the global companies our bod has refered to for the last few years !

Looks like this has nothing to do with Byhealth so I assume it s One of the other ongoing projects, “ The Company will provide scientific and technical support for Fruitflow® to DSM and BY-HEALTH throughout the collaboration.
We have a number of other ongoing projects in progress in China.”.

Alf know what your saying but I feel By-Health have spent big money on this , think they know their market and will know when and where to launch , as for the rest of the world you might be right .

Gixer maybe not an Rns but something on the news page like Bom Korea, or livextra yang

You would think it worthy of mention from pxs , especially if they are already selling even without blue cap !

Dare we hope for an end of 1st quarter update !

Ok I missed that one then , cheers

IT Does sound like they are committed to selling ff products nationally , which will be great news for us , it’s just when !

Gixer I wonder if the new name will be “Light Complexing”. And that’s the reason The Fruitflow logo has been ditched ! Also states they have spent millions of dollars testing the drug .

HTTPS://patentscope.wipo.int/search/en/detail.jsf?docId=US293957659&_cid=P10-KBRAPQ-95618-1

Https://patentscope.wipo.int/search/en/detail.jsf?docId=US293957659&_cid=P10-KBRAPQ-95618-1.
Withania somnifera, commonly called ashwagandha, is a winter cherry tropical to the Solanaceae family that is used in treating a wide variety of illnesses including asthma, diabetes, hypertension, stress, arthritic diseases, and cancer.
Sent from my iPad

Did a search for Fruitflow and this came up . AINST AIR POLLUTION RELATED DISEASES
US - 30.04.2020
Int.Class
A61K 31/585
Appl.No 16605627
Applicant DSM IP Assets B.V.
Inventor Igor BENDIK
The present invention relates to systemic detoxification by using extracts of Withania somnifera (ashwagandha) and its Nrf2-activating components withaferin-A, 12-deoxywithastramonolide, and Quresimine A. When ingested, the transcription factor Nrf2, which is a crucial element in intracellular detoxification pathways, leads to elimination of potentially toxic compounds. In parallel, the expression of inflammatory cytokines is decreased. Therefore, the extract can be used to reduce the adverse effects of air pollution generally (and especially of particulate air pollution), which includes: cardiovascular problems, respiratory diseases, and chronic inflammation of tissues that come into contact with air borne particles.

And it was delayed last year because they were waiting for the news of tie up with By health

Unless they have news of Blue hat I find it difficult to believe they will give a trading update , otherwise what are they going to say , “all progressing well again “ !

Aquisition unlikely as I think they got in a bit of trouble with life space if you read the last years report ,much more likely are prospects of selling 6 or 7 new products in the Chinese market containing a fantastic health product ‘Fruitflow ‘ only my opinion of course .

Heading for £4b. Something’s brewing imo

Just got price .8145

Tried a dummy sell ,couldn’t get a price !

Wellsite I don’t condone violence but if it were me who sold i’d Want to kick Zeus

Everhopeful looks like you were spot on with your prediction !